COVID-19 Update

OHSU

M. Curlin

How Is Immunosuppression Managed in Rare Neuroimmune Disorders? Trea…

Siegel Rare Neuroimmune Association

B. Greenberg, M. Levy

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Underst…

Jaime Seltzer

The Role of the Nervous System In Chronic Illness

The Institute for Neuro-Immune Medicine

H. Pomroy, D. Kantor

COVID and Multiple Sclerosis

Anthony Reder

Colchicine for the Management of COVID-19, Recent Statistics on SARS…

MicrobeTV

D. Griffin, V. Racaniello

Alopecia Areata Triggered by COVID-19 Vaccines

Evidence-Based Hair

J. Donovan

COVID-19 Vaccine Response in People With Multiple Sclerosis Treated …

Matthew A. Tremblay

Recent Statistics on SARS-CoV-2 Infection, Guidelines for Spring Adm…

MicrobeTV

D. Griffin, V. Racaniello

Multiple Sclerosis and COVID-19: What We Have Learned So Far

OHSU

V. Yadav

Progress in the Use of Transplantation for Autoimmune Disease

Louisville Hematology Highlights

R. Nash

Two Years into COVID, Now What? Covid and Multiple Sclerosis Update …

OHSU

V. Yadav, M. Curlin, D. Christensen

Multiple Sclerosis and COVID-19: Outcomes, Complications, Vaccine Co…

Cleveland Clinic Department of Rheumatic and Immunologic Disease

B. Moss

An Approach to a Critically Ill Pregnant Patient

Houston Methodist

K. K. Guntupalli

Planetary Health: What Does This Mean at My Hospital?

McMaster University Department of Medicine

Z. Khalid, M. Sergeant

COVID-19 Round up in Other Immune-Mediated Inflammatory Diseases: Sp…

Cleveland Clinic Department of Rheumatic and Immunologic Disease

L. Calabrese, C. Calabrese, R. Ungaro, B. Moss, J. M. Gelfand

COVID-19 & Multiple Sclerosis: Can Immunosuppressive Therapy Decreas…

Gavin Giovannoni

RA & Multiple Sclerosis Management: Can MS and RA Coexist? Do RA Pat…

RheumNow

J. Cush

S1P1 Receptor Modulators for Treatment of Relapsing Multiple Scleros…

University of Miami

S. Delgado

New Therapy Options for Neuromyelitis Optica Spectrum Disorder: Ecul…

University of Miami

R. Flores Gonzalez